TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/21/07 12:17 | 12/20/07 | INGN | Introgen Therapeutics Inc | Health | Drug | Pharmaceutical Preparations | Parker David L | TX | O | VP | M.d | 10 | 0.5190 | 0 | 20 | 28 | 92 | D | |||||||||||||||
9/6/06 15:20 | 9/5/06 | INGN | Introgen Therapeutics Inc | Health | Drug | Pharmaceutical Preparations | Parker David L | TX | O | SVP | M.d | 8 | 0.5190 | 0 | 15 | 26 | 72 | D | |||||||||||||||
1/4/06 15:27 | 12/30/05 | INGN | Introgen Therapeutics Inc | Health | Drug | Pharmaceutical Preparations | Parker David L | TX | O | VP | M.d | 8 | 0.5190 | 0 | 15 | 36 | 57 | D | |||||||||||||||
2/9/04 15:57 | 2/6/04 | INGN | Introgen Therapeutics Inc | Health | Drug | Pharmaceutical Preparations | Parker David L | TX | O | VP | M.d | 5 | 0.5190 | 0 | 10 | 31 | 42 | D | |||||||||||||||
1/2/04 14:55 | 12/31/03 | INGN | Introgen Therapeutics Inc | Health | Drug | Pharmaceutical Preparations | Parker David L | TX | O | VP | M.d | 5 | 0.5190 | 0 | 10 | 46 | 32 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |